Blog
Lemonade Is Ripe for Short Squeezing
It's been a tough year for Lemonade (NYSE: LMND) investors. Share prices of the strangely named insurance technology company are down more than 60% from their January peak and are still within reach
Here's Why DraftKings Spent Almost Half a Billion Dollars to Acquire Users
Fantasy sports company DraftKings (NASDAQ: DKNG) has crushed the market average since the beginning of 2020, up nearly 400% during this short time. Investors are cheering the company's robust growth
AMC Stock Has a Lot to Prove This Week
If you like stories of intrigue and unexpected plot twists, you've come to the right place. AMC Entertainment Holdings (NYSE: AMC) reports fresh financial results this week, shortly after Monday's
5 Stocks I Own and Will Add To If the Stock Market Crashes
Occasional stock market meltdowns are inevitable. If you're going to be a stock investor hoping for great long-term gains, you'll have to accept that -- and expect corrections and crashes every few
Why Sibanye Stillwater Stock Surged 15% in October
Shares of Sibanye Stillwater (NYSE: SBSW) jumped 15.1% in October, according to data provided by S&P Global Market Intelligence. Several factors fueled the precious metal mining stock's rally,
2 Things Shiba Inu Investors Could Learn From Dogecoin's Collapse
The stock market is an exciting place filled with innovative companies reshaping our future. History shows that a long-term approach to the market yields the best returns, evidenced by the 3,700%
Why Moderna Stock Faltered In October
Shares of the messenger RNA (mRNA) drug and vaccine developer Moderna (NASDAQ: MRNA) slipped by a noteworthy 10.7% during the month of October, according to data from S&P Global Market Intelligence
Goldman Sachs Crushes Expectations Once Again
Goldman Sachs (NYSE: GS) released its third-quarter earnings in mid-October, continuing a massively successful year for the investment banking giant. In this Fool Live clip, recorded on Oct. 18
3 Undervalued Stocks You Can Buy Today
If you feel like valuations on Wall Street have grown a little too frothy over the course of the past few months, you're not crazy. Up by more than 100% since its March 2020 low, the S&P 500
Here's Why Merck Stock Vaulted Higher in October
Shares of the pharma giant Merck (NYSE: MRK) rose by 17.2% over the course of October, according to data from S&P Global Market Intelligence. The drugmaker's stock caught fire last month for two
3 Stocks to Avoid This Week
I've been picking stocks to avoid every week, identifying names that I think could be challenged in the coming days. My three stocks to avoid last week were on the move -- down 17%, down 13%, and up
Why Snowflake Surged 17% in October
Shares of cloud-based data warehousing company Snowflake (NYSE: SNOW) surged 17% in October, according to data from S&P Global Market Intelligence.
Snowflake didn't report earnings in October, but
Why Latch Fell 21.1% in October
Shares of property technology company Latch (NASDAQ: LTCH) fell 21.1% in October, according to data from S&P Global Market Intelligence.
There wasn't much in the way of company-specific news during
Why Arista Networks Rose 19.2% in October
Shares of Arista Networks (NYSE: ANET) rose 19.2% in October, according to data from S&P Global Market Intelligence.
The company didn't report earnings until November, which proved to be another
Is Ford's Junk Bond Buyback Good News For Investors?
After taking on billions in debt to weather the 2020 economic storms of COVID-19, Ford (NYSE: F) announced on Nov. 4 that it's freeing itself from approximately $5 billion worth of junk bonds
Why Protagonist Therapeutics Stock Skyrocketed 80.2% Last Month
Shares of Protagonist Therapeutics (NASDAQ: PTGX) soared 80.2% in October, according to data from S&P Global Market Intelligence. The stock surged after the U.S. Food and Drug Administration (FDA)
2 Best Value Stocks to Buy Right Now
The term "value stock" often refers to companies that trade at cheap valuations in relation to their annual earnings or cash flows. While many of these companies are valued cheaply due to slow or
Why I'm Doubling Down on This CRE Sector
Arguably the hottest sector in commercial real estate (CRE) right now is industrial real estate. Not only has industrial real estate on average outperformed all other real estate sectors for the
Sturm, Ruger Dividend Slashed 21% -- but It's Not What You Think
Sturm, Ruger (NYSE: RGR) investors might have been surprised to see that even though the company's fiscal third-quarter firearms sales jumped 22% year over year and per-share profits were 42%
Why Lucid Stock Jumped 46% in October and Continues to Rally
Electric vehicle (EV) stocks have been all over the news in recent weeks, but Lucid Group (NASDAQ: LCID) stumped everyone with the kind of attention it received: Its shares surged a whopping 45.7%
Even After Spending to Promote Further Growth, DigitalOcean Remains Highly Profitable
Since its IPO in early 2021, shares of DigitalOcean Holdings (NYSE: DOCN) are up an incredible 118% as of this writing. The third-quarter earnings update showcased the momentum this cloud computing
Skillz Stays Aggressive: Spends 112% of Revenue on Sales and Marketing in Q3
Skillz (NYSE: SKLZ) is an exciting gaming company. Unlike many of its peers, the company offers its players the opportunity to wager on games played against each other. That inherently makes the
Etsy's 3 Underrated Growth Drivers in Q3 2021
Etsy (NASDAQ: ETSY), an online marketplace for vintage and handmade goods, reported another quarter of solid earnings last week. The value of merchandise sold on the platform and resulting revenue
This REIT Just Abandoned Its Strategy
Back in 2015, Seritage Growth Properties (NYSE: SRG) was formed to buy a substantial chunk of Sears Holdings' real estate, giving the struggling retail icon a $2.7 billion cash infusion.
At the time
3 Best Biotech Stocks to Buy in November
For income investors, building a diversified portfolio of dividend stocks should be a top priority. That's because owning a wide array of stocks that span numerous industries reduces your risk


